{'fraction_non_alphanumeric': 0.014678899082568808, 'fraction_numerical': 0.003669724770642202, 'mean_word_length': 5.658536585365853, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Low‐dose hydrocortisone treatment for patients with septic shock: A pilot study comparing 3 days with 7 days

Background and objective:  Although there is controversy regarding the benefit of low‐dose corticosteroid therapy in patients with septic shock, the Surviving Sepsis Campaign has advocated that low‐dose intravenous hydrocortisone be used to treat adult septic shock patients. This study investigated the effect of the duration of a stress dose of hydrocortisone on survival of septic shock patients with relative adrenal insufficiency.